Advanced Oncotherapy is based in London, United Kingdom. It has raised $47M in total funding. Backed by Cosylab DD, Philippe Glatz, Ahlström Capital.
Advanced Oncotherapy funding overview
Advanced Oncotherapy is based in London, United Kingdom. Advanced Oncotherapy has raised $47M in total disclosed funding. That places its disclosed total in the $25M–$100M range. The round record for Advanced Oncotherapy runs through 2021; nothing later has been disclosed. Investors on record include Cosylab DD, Philippe Glatz, Ahlström Capital, DNCA Investments. 4 distinct backers are named across the disclosed rounds.
Advanced Oncotherapy at a glance
Total raised
$47M
Latest round date
August 2021
Headquarters
London, United Kingdom
Notable investors
Cosylab DD, Philippe Glatz, Ahlström Capital, DNCA Investments
Frequently asked about Advanced Oncotherapy funding
How much has Advanced Oncotherapy raised?
Advanced Oncotherapy has raised $47M in total disclosed funding across the rounds on record.
Who has invested in Advanced Oncotherapy?
Cosylab DD, Philippe Glatz, Ahlström Capital, DNCA Investments are named among the investors backing Advanced Oncotherapy.
What was the latest Advanced Oncotherapy funding round?
No round stage has been disclosed for Advanced Oncotherapy.
Where is Advanced Oncotherapy based?
Advanced Oncotherapy is based in London, United Kingdom.
When did Advanced Oncotherapy last raise?
The last disclosed Advanced Oncotherapy round closed in August 2021.
Totals shown for Advanced Oncotherapy aggregate every disclosed round on file. To see how that compares, browse the companies in London and the investors behind them below.
